Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Shares Outstanding (Weighted Average) (2022 - 2023)

Historic Shares Outstanding (Weighted Average) for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to $2.0 million.

  • Therapeutics' Shares Outstanding (Weighted Average) fell 9644.64% to $2.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.0 million, marking a year-over-year decrease of 9644.64%. This contributed to the annual value of $54.9 million for FY2022, which is N/A changed from last year.
  • Therapeutics' Shares Outstanding (Weighted Average) amounted to $2.0 million in Q3 2023, which was down 9644.64% from $2.0 million recorded in Q2 2023.
  • Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $55.2 million during Q3 2022, with a 5-year trough of $2.0 million in Q1 2023.